Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile
Elisabetta Bonzano MD, PhD

@to_be_elizabeth

Radiation Oncologist, MD, PhD Fondazione IRCCS Policlinico San Matteo @UniPv - MIUR Qualified Associate Professor - PhD in Experimental Medicine

ID: 53770451

calendar_today04-07-2009 21:57:23

859 Tweet

820 Followers

278 Following

OncoAlert (@oncoalert) 's Twitter Profile Photo

An honor to present our OncoAlert #BreastCancer Faculty Erika Hamilton, MD 🇺🇸 for the OncoAlert VJ Oncology Journal Club Dr Hamilton of Sarah Cannon Docs Guides us through her publication on the NEJM: Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer

Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Characteristics of real-world NATALEE- and monarchE-eligible populations with HR+/HER2− early breast cancer: a United States Electronic Health Records database analysis✨ esmoopen.com/article/S2059-… Paolo Tarantino G Curigliano MD PhD Hope Rugo Erika Hamilton, MD Stephanie Graff, MD, FACP, FASCO OncoAlert

📌 Characteristics of real-world NATALEE- and monarchE-eligible populations with HR+/HER2− early breast cancer: a United States Electronic Health Records database analysis✨

esmoopen.com/article/S2059-…
<a href="/PTarantinoMD/">Paolo Tarantino</a> <a href="/curijoey/">G Curigliano MD PhD</a> <a href="/hoperugo/">Hope Rugo</a> <a href="/ErikaHamilton9/">Erika Hamilton, MD</a> <a href="/DrSGraff/">Stephanie Graff, MD, FACP, FASCO</a> <a href="/OncoAlert/">OncoAlert</a>
OncoAlert (@oncoalert) 's Twitter Profile Photo

We Are ALL OncoAlert 🚨 3⃣9⃣k of our Oncology Colleagues & Going STRONG ...and we are JUST Getting Started Entirely by Colleagues.....For Colleagues🌐 Our Gratitude for your support! Gil Morgan, MD #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz

OncoAlert (@oncoalert) 's Twitter Profile Photo

A warm invitation to MEDTALK at ESMO 2025, hosted by MEDSIR Register: buff.ly/uLHrrkY October 19th, 7:00 PM–8:30 PM in Berlin, Germany. Explore how theranostics is revolutionizing oncology by uniting diagnostic imaging and targeted therapy to offer new hope for

A warm invitation to MEDTALK at ESMO 2025, hosted by <a href="/wearemedsir/">MEDSIR</a>

Register: buff.ly/uLHrrkY 

 October 19th, 7:00 PM–8:30 PM in Berlin, Germany. Explore how theranostics is revolutionizing oncology by uniting diagnostic imaging and targeted therapy to offer new hope for
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights✨ ascopubs.org/doi/10.1200/OP… 👉🏻 Why Omit SLNB? Balancing Benefits Versus Potential Harms 👉🏻 How Does SLNB Impact Radiation Therapy Decisions? 👉🏻 How Does SLNB Omission Impact Systemic

📌 Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights✨

ascopubs.org/doi/10.1200/OP…

👉🏻 Why Omit SLNB? Balancing Benefits Versus Potential Harms
👉🏻 How Does SLNB Impact Radiation Therapy Decisions?
👉🏻 How Does SLNB Omission Impact Systemic
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

‼️REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…‼️📩📩📩 👉🏻The OncoAlert 🚨Newsletter Now Out !! Covering Jun 12-19, 2025 🗓️ ✅Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision

Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 PROshot: Radiation Alone for Low-risk, Early-stage Breast Cancer, Stereotactic Body Radiation Therapy for Advanced and Recurrent Hepatocellular Carcinoma, and the Role of Cetuximab in Treating Head and Neck Squamous Cell Carcinoma 🔗practicalradonc.org/article/S1879-… OncoAlert

📌 PROshot: Radiation Alone for Low-risk, Early-stage Breast Cancer, Stereotactic Body Radiation Therapy for Advanced and Recurrent Hepatocellular Carcinoma, and the Role of Cetuximab in Treating Head and Neck Squamous Cell Carcinoma

🔗practicalradonc.org/article/S1879-…

<a href="/OncoAlert/">OncoAlert</a>
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer 🔗pmc.ncbi.nlm.nih.gov/articles/PMC12… 👉🏻 CAR-T ➡️ TNBC ✨ targeting B7-H3 and CSPG4 simultaneously would provide CAR-T cells preventing tumor escape. OncoAlert #OncoAlertAF Roberto Borea, MD

📌 B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer

🔗pmc.ncbi.nlm.nih.gov/articles/PMC12…

👉🏻 CAR-T ➡️  TNBC

✨ targeting B7-H3 and CSPG4 simultaneously would provide CAR-T cells preventing tumor escape.

<a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF <a href="/RobertoBoreaMD/">Roberto Borea, MD</a>
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline 🔗 practicalradonc.org/article/S1879-… OncoAlert #OncoAlertAF #RadOnc

📌 Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline

🔗 practicalradonc.org/article/S1879-…

<a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF #RadOnc
Breast International Group (@bigxresearch) 's Twitter Profile Photo

We’re excited to welcome the new and returning members of BIG’s Executive Board, starting 1 July 2025! Thank you to our outgoing members for their incredible dedication and leadership. Together, we continue advancing international breast cancer research. 💗

We’re excited to welcome the new and returning members of BIG’s Executive Board, starting 1 July 2025!

Thank you to our outgoing members for their incredible dedication and leadership.

Together, we continue advancing international breast cancer research. 💗
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Inavolisib-Based Triplet Therapy for PIK3CA-Mutated Hormone Receptor+/HER2- Breast Cancer: Clinical Implications and Practical Considerations 🔗 ascopubs.org/doi/pdf/10.120… OncoAlert #OncoAlertAF Dana-Farber’s Breast Oncology Center Sara Tolaney Erica Mayer Guilherme Nader Marta

📌 Inavolisib-Based Triplet Therapy for PIK3CA-Mutated Hormone Receptor+/HER2- Breast Cancer: Clinical Implications and Practical Considerations

🔗 ascopubs.org/doi/pdf/10.120…

<a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/elmayermd/">Erica Mayer</a> <a href="/GuiNaderMarta/">Guilherme Nader Marta</a>
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade 🔗 ascopubs.org/doi/10.1200/GO… #Oncology #BreastCancer #HealthEquity OncoAlert #OncoAlertAF JCO Global Oncology

📌 Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade

🔗 ascopubs.org/doi/10.1200/GO…

#Oncology #BreastCancer #HealthEquity

<a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF <a href="/JCOGO_ASCO/">JCO Global Oncology</a>
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

‼️REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… 📩📩📩 ➡️The OncoAlert 🚨Newsletter Now Out !! Covering June 23-July 3, 2025 🗓️ Discussing: ✅ShortHER in #BreastCancer and more ⤵️

OncoAlert (@oncoalert) 's Twitter Profile Photo

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial buff.ly/Fmhuyub In a randomized study of 407 patients with de novo stage IV #BreastCancer , primary tumor

Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial 

buff.ly/Fmhuyub 

In a randomized study of 407 patients with de novo stage IV #BreastCancer , primary tumor
OncoAlert (@oncoalert) 's Twitter Profile Photo

The OncoAlert VJ Oncology JOURNAL CLUB This week we have the pleasure to bring you Icro Meattini 🇮🇹of the University of Florence Discussing: Multimodal De-Escalation Strategies in Early Breast Cancer on the ASCO Educational Book Direct Link to Publication